Menu

Blog

Archive for the ‘biotech/medical’ category: Page 590

Jun 10, 2023

‘Dr. Deep’ resurfaces after a record 100 days living underwater in Florida

Posted by in category: biotech/medical

KEY LARGO, Fla. — A university professor who spent 100 days living underwater at a Florida Keys lodge for scuba divers resurfaced Friday and raised his face to the sun for the first time since March 1.

Dr. Joseph Dituri set a new record for the longest time living underwater without depressurization during his stay at Jules’ Undersea Lodge, submerged beneath 30 feet of water in a Key Largo lagoon.

The diving explorer and medical researcher shattered the previous mark of 73 days, two hours and 34 minutes set by two Tennessee professors at the same lodge in 2014.

Jun 10, 2023

Sol Reader is a VR headset exclusively for reading books

Posted by in categories: augmented reality, biotech/medical, computing, mobile phones, neuroscience, virtual reality, wearables

We’ve been waxing lyrical (and critical) about Apple’s Vision Pro here at TechCrunch this week – but, of course, there are other things happening in the world of wearable tech, as well. Sol Reader raised a $5 million seed round with a headset that doesn’t promise to do more. In fact, it is trying to do just the opposite: Focus your attention on just the book at hand. Or book on the face, as it were.

“I’m excited to see Apple’s demonstration of the future of general AR/VR for the masses. However, even if it’s eventually affordable and in a much smaller form factor, we’re still left with the haunting question: Do I really need more time with my smart devices,” said Ben Chelf, CEO at Sol. “At Sol, we’re less concerned with spatial computing or augmented and virtual realities and more interested in how our personal devices can encourage us to spend our time wisely. We are building the Sol Reader specifically for a single important use case — reading. And while Big Tech surely will improve specs and reduce cost over time, we can now provide a time-well-spent option at 10% of the cost of Apple’s Vision.”

The device is simple: It slips over your eyes like a pair of glasses and blocks all distractions while reading. Even as I’m typing that, I’m sensing some sadness: I have wanted this product to exist for many years – I was basically raised by books, and lost my ability to focus on reading over the past few years. Something broke in me during the pandemic – I was checking my phone every 10 seconds to see what Trump had done now and how close we were to a COVID-19-powered abyss. Suffice it to say, my mental health wasn’t at its finest – and I can’t praise the idea of Sol Reader enough. The idea of being able to set a timer and put a book on my face is extremely attractive to me.

Jun 10, 2023

Taurine Deficiency As A Driver Of Aging: What’s My Data (Youthful Or Aged)?

Posted by in categories: biotech/medical, genetics, life extension

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Continue reading “Taurine Deficiency As A Driver Of Aging: What’s My Data (Youthful Or Aged)?” »

Jun 10, 2023

Ep#04 Aubrey De Grey : What if we don’t have to die

Posted by in categories: biotech/medical, life extension

This is a new channel with Liz Parrish. This is an hour with Aubrey.


Most people consider #aging to be a normal part of the cycle of #life and #death. But, did you know that some people see aging merely as a disease?
Which means that they believe there is a cure for aging.
And, these people are in pursuit of that cure.

Continue reading “Ep#04 Aubrey De Grey : What if we don’t have to die” »

Jun 10, 2023

Seasonal infections

Posted by in categories: biotech/medical, health

With the Monsoon rains comes many infectious diseases that can pose health risks, such as mosquito-borne malaria and dengue.

Early suggestion for a likely diagnosis can save lives. However, many infections share the same symptoms and clinical findings. The combination of a detailed patient anamnesis, physical examination, and laboratory data is therefore a prerequisite for identification of the likely cause.

Jun 9, 2023

Study reveals first genetic locus for voice pitch

Posted by in categories: biotech/medical, genetics, health

In a paper published in Science Advances, an international team led by deCODE genetics, a subsidiary of Amgen, reveals the discovery of sequence variants in the gene ABCC9 that influence the pitch of voices.

Speaking is one of the most characteristic human behaviors, and yet the genetic underpinnings of voice and are largely unknown. In the first study of its kind, the scientists combined speech recordings from almost 13,000 Icelanders with data, in the sequence of the genome, to search for common variants in ABCC9 that are associated with a higher-pitched voice.

Continue reading “Study reveals first genetic locus for voice pitch” »

Jun 9, 2023

A potential milestone in cancer therapy: Team discovers weak spot in prostate cancer cells

Posted by in categories: biotech/medical, nanotechnology

Prostate cancer is the most common non-skin cancer in men worldwide. According to international estimates about one in six men will get prostate cancer during their lifetime and worldwide, over 375,000 patients will die from it each year. Tumor resistance to current therapies plays an essential role in this and new approaches are therefore urgently needed.

Now an international research team from the University of Bern, Inselspital Bern and the University of Connecticut has identified a previously unknown weak spot in . This weak spot is possibly also present in other . The study was led by Mark Rubin from the Department for Biomedical Research (DBMR) and Center for Precision Medicine (BCPM) at the University of Bern and Inselspital Bern, and Rahul Kanadia from the Department of Physiology and Neurobiology and the Institute for Systems Genomics at the University of Connecticut. The research results have been published in the journal Molecular Cell.

“We took a closer look at a certain molecular machine called the ,” explains Anke Augspach, lead author of the study and researcher from the Department for BioMedical Research (DBMR). “It plays an important role in the translation of genes into proteins. In this process, the spliceosome separates parts of the gene that are not needed for the production of the protein and fuses the other parts.”

Jun 9, 2023

Deadly heart condition reversed in 3 patients for the first time

Posted by in category: biotech/medical

Researchers have observed spontaneous reversal of the devastating heart condition transthyretin cardiac amyloidopathy for the first time, edging closer to a cure.

Jun 9, 2023

Quantum materials: Electron spin measured for the first time

Posted by in categories: biotech/medical, computing, quantum physics

An international research team has succeeded for the first time in measuring the electron spin in matter—i.e., the curvature of space in which electrons live and move—within “kagome materials,” a new class of quantum materials.

The results obtained—published in Nature Physics —could revolutionize the way quantum materials are studied in the future, opening the door to new developments in quantum technologies, with in a variety of technological fields, from to biomedicine, from electronics to quantum computers.

Success was achieved by an international collaboration of scientists, in which Domenico Di Sante, professor at the Department of Physics and Astronomy “Augusto Righi,” participated for the University of Bologna as part of his Marie Curie BITMAP research project. He was joined by colleagues from CNR-IOM Trieste, Ca’ Foscari University of Venice, University of Milan, University of Würzburg (Germany), University of St. Andrews (UK), Boston College and University of Santa Barbara (U.S.).

Jun 9, 2023

Telemedicine visits cut health system employee care costs

Posted by in categories: biotech/medical, finance, health

Visits with a 24/7, co-payment-free telemedicine program established by Penn Medicine for its employees were 23% less expensive than in-person visits for the same conditions, according to a new analysis published in the American Journal of Managed Care.

Researchers at the Perelman School of Medicine at the University of Pennsylvania found that the per-visit costs for the , called Penn Medicine OnDemand, averaged $380 while in-person encounters in primary care offices, emergency departments, or during the same timeframe cost $493 to conduct, a $113 difference per patient.

“The conditions most often handled by OnDemand are low acuity—non-urgent or semi-urgent issues like respiratory infections, sinus infections, and allergies—but incredibly common, so any kind of cost reduction can make a huge difference for controlling employee benefit costs,” said the study’s lead researcher, Krisda Chaiyachati, MD, an adjunct assistant professor of Medicine at Penn Medicine, who previously served as medical director of Penn Medicine OnDemand and now is the physician lead for Value-based Care and Innovation at Verily. “This research shows the clear financial benefits when hospitals and offer telemedicine services directly to their own employees.”

Page 590 of 2,729First587588589590591592593594Last